Eric C. Wiseman
Known title: DirectorCIK: 0001237851
Associated companies
Transaction History
| CI | ▲ Buy | Grant | 782 | $0 | 4/22/2026 | View on chart |
| CI | ▲ Buy | Grant | 638 | $0 | 4/23/2025 | View on chart |
| CI | ▲ Buy | Grant | 539 | $0 | 4/24/2024 | View on chart |
| CI | ▲ Buy | Grant | 765 | $0 | 4/26/2023 | View on chart |
| CI | ▲ Buy | Grant | 757 | $0 | 4/27/2022 | View on chart |
| CI | ▲ Buy | Grant | 199 | $0 | 2/28/2022 | View on chart |
| CI | ▲ Buy | Grant | 247 | $0 | 11/30/2021 | View on chart |
| CI | ▲ Buy | Grant | 224 | $0 | 8/31/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Cigna Focuses on Data-Driven Care and Valuation Metrics
Recent coverage highlights Cigna's strategic shift toward data-driven care through its Health Sense initiative, positioning it as a key differentiator in the healthcare sector. Analysts are also examining the stock's valuation, noting a forward P/E that suggests value despite ongoing earnings risks. With the stock trading near its 52-week high, these developments provide context for its current market position relative to peers like UnitedHealth.
Cigna Focuses on Data-Driven Care and Valuation Metrics. Recent coverage highlights Cigna's strategic shift toward data-driven care through its Health Sense initiative, positioning it as a key differentiator in the healthcare sector. Analysts are also examining the stock's valuation, noting a forward P/E that suggests value despite ongoing earnings risks. With the stock trading near its 52-week high, these developments provide context for its current market position relative to peers like UnitedHealth.